tau retinal tracer (Amydis)

N/A

Report date: 2025/01/26 17:24:01
NME

Base Information

Drug Nametau retinal tracer (Amydis)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsEye DiseasesAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAmydis Inc
China Registration ClassN/A

Develop Information

Active CompaniesAmydis Inc
Inactive CompaniesN/A
Active IndicationsEye DiseasesAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A